The clinical course of idiopathic membranoproliferative glomerulonephritis type 1

Background : The manifestation of Membranoproliperative glomerulonephritis (MPGN) is variable from asymptomatic hematuria, nephrotic syndrome to advanced chronic kidney disease. The etiology, pathogenesis, and treatment of MPGN are unclear. The incidence of idiopathic MPGN is also rare in Korea, and the clinical course was rarely studied. So we investigated clinical course of idiopathic MPGN type 1. Methods : From March 1990 to November 2004, renal biopsy was done in about 1500 patients in Dong-A universty hospital. Among them, 16 patients were diagnosed as idiopathic MPGN. Fourteen patients were observed over 6 months. We analyzed clinical data of these patients retrospectively. Results : Male to female ratio of total 16 patients is 2.2:1. Mean age of patients was 37.6 years (14-76years) at the time of diagnosis. Thirteen cases (81%) had nephrotic range proteinuria, 8 cases (50%) had hypertention, 12 cases (75%) had edema, and 4 cases (25%) had decreased renal fuction (serum creatinine>1.2 mg/dL) at the time of diagnosis. Average observation time was 55.7±37.4 (6-122)months. Six cases ended up with progressive renal failure. Three cases achieved complete remission. Renal survival time for 50% of cases was 92 months. In our study, edema and decreased renal fucntion at the time of diagnosis were related with later development of progressive renal failure (p<0.05). Of the total 14 cases, 4 cases ware treated conservatively, 6 cases were treated with anti-platelet agents, and 4 cases were treated with anti-platelet agents and prednisone. In conservative treatment group, 1 case ended up with progressive renal failure and 1 case achieved complete remission. In anti-platelet agents treatment goup, 4 cases ended up progressive renal failure. In combined anti-platelet agents and prednisone treatment group, 1 case ended up progressive renal failure and 2 cases achieved complete

[1]  G. Lagrue,et al.  Renal survival in membranoproliferative glomerulonephritis (MPGN): Role of long-term treatment with non-steroid anti-inflammatory drugs (NSAID) , 2006, International Urology and Nephrology.

[2]  Hiroshi Sato,et al.  [Membranoproliferative glomerulonephritis]. , 2004, Nihon rinsho. Japanese journal of clinical medicine.

[3]  I J Choi,et al.  An analysis of 4,514 cases of renal biopsy in Korea. , 1991, Yonsei medical journal.

[4]  D. Painter Renal Disease: Classification and Atlas of Glomerular Diseases , 1996 .

[5]  D. Han,et al.  An analysis of 2361 cases of renal biopsy in Korea. , 1991, Yonsei medical journal.

[6]  A. J. Mcadams,et al.  Differences between membranoproliferative glomerulonephritis types I and III in clinical presentation, glomerular morphology, and complement perturbation. , 1987, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[7]  K. Ang,et al.  Variations of primary glomerulonephritis incidence in a rural area of 400,000 inhabitants in the last decade. , 1987, Nephron.

[8]  C. Cardella,et al.  Results of a controlled drug trial in membranoproliferative glomerulonephritis. , 1985, Kidney international.

[9]  G. Banfi,et al.  Is membranoproliferative glomerulonephritis really decreasing? A multicentre study of 1,548 cases of primary glomerulonephritis. , 1985, Nephron.

[10]  V. Fuster,et al.  Membranoproliferative glomerulonephritis. A prospective clinical trial of platelet-inhibitor therapy. , 1984, The New England journal of medicine.

[11]  C. Swainson,et al.  Mesangiocapillary glomerulonephritis: A long‐term study of 40 cases , 1983, The Journal of pathology.

[12]  S. Zimmerman,et al.  Prospective trial of warfarin and dipyridamole in patients with membranoproliferative glomerulonephritis. , 1983, The American journal of medicine.

[13]  G. Haycock,et al.  Idiopathic mesangiocapillary glomerulonephritis. Comparison of types I and II in children and adults and long-term prognosis. , 1983, The American journal of medicine.

[14]  McEnery Pt,et al.  Membranoproliferative glomerulonephritis: improved survival with alternate day prednisone therapy. , 1980 .

[15]  C. Rance,et al.  Membranoproliferative glomerulonephritis type 1: comparison of natural history in children and adults. , 1979, Clinical nephrology.

[16]  K. E. Holley,et al.  Idiopathic membranoproliferative (mesangiocapillary) glomerulonephritis: a clinicopathologic study. , 1979, Mayo Clinic proceedings.

[17]  E. Schneeberger,et al.  Membranoproliferative glomerulonephritis (MPGN type I) and dense deposit disease (DDD) in children. , 1978, Clinical nephrology.

[18]  R. R. Robinson,et al.  Membranoproliferative glomerulonephritis with dense intramembranous alterations. A clinicopathologic study. , 1977, Laboratory investigation; a journal of technical methods and pathology.

[19]  D. Droz,et al.  Dense deposits disease. , 1977, Nephron.

[20]  C. Bazzi,et al.  The prognostic value of some clinical and histological parameters in membranoproliferative glomerulonephritis (MPGN): report of 112 cases. , 1977, Nephron.

[21]  Y. Vanrenterghem,et al.  Treatment of chronic glomerulonephritis with a combination of indomethacin and cyclophosphamide. , 1975, Clinical nephrology.

[22]  A. J. Mcadams,et al.  Mesangiocapillary glomerulonephritis: changes in glomerular morphology with long-term alternate-day prednisone therapy. , 1975, The Journal of pediatrics.

[23]  M. Gubler,et al.  Idiopathic membranoproliferative glomerulonephritis in children. Report of 105 cases. , 1973, Clinical nephrology.

[24]  E. Glasgow,et al.  The clinical features and prognosis of patients with normocomplementemic mesangiocapillary glomerulonephritis. , 1973, Clinical nephrology.

[25]  P. Kincaid‐smith,et al.  THE TREATMENT OF CHRONIC MESANGIOCAPILLARY (MEMBRANOPROLIFERATIVE) GLOMERULONEPHRITIS WITH IMPAIRED RENAL FUNCTION , 1972, The Medical journal of Australia.

[26]  A. Marchand,et al.  Mixed membranous and proliferative glomerulonephritis. A correlative light, immunofluorescence, and electron microscopic study. , 1970, Laboratory investigation; a journal of technical methods and pathology.

[27]  E. Glasgow,et al.  Papers and Originals Membranoproliferative Glomerulonephritis and Persistent , 2006 .

[28]  A. J. Mcadams,et al.  Hypocomplementemic and normocomplementemic persistent chronic glomerulonephritis. Clinical and pathologic characteristics , 1965 .

[29]  C. Janeway,et al.  The Beta1c Globulin in Childhood Nephrotic Syndrome , 1965 .

[30]  C. Janeway,et al.  THE BETA-1C GLOBULIN IN CHILDHOOD NEPHROTIC SYNDROME: LABORATORY DIAGNOSIS OF PROGRESSIVE GLOMERULONEPHRITIS. , 1965, The New England journal of medicine.